← dreamlab

Addiction

The prefrontal cortex loses its vote. Reward circuits hijack decision-making, and willpower becomes irrelevant — the brain has been physically restructured to prioritize the substance over everything else.

Conventional Treatment

Detox, then therapy, then hope. MAT (medication-assisted treatment) — methadone, buprenorphine, naltrexone — helps with opioids but doesn't exist for most substances. Behavioral therapies (CBT, motivational interviewing, 12-step) have modest long-term success rates. Relapse rates hover around 40–60% across all substance categories. The brain damage from chronic substance use — prefrontal hypoperfusion, dopamine receptor downregulation, white matter degradation — is rarely treated directly. Recovery programs address behavior while the injured brain struggles to cooperate.

Learned
Tell me more
Not helpful
Evidence for Hyperbaric Oxygen Therapy

Harch et al. (2017) published in Medical Gas Research a case report showing that HBOT at 1.5 ATA produced significant cognitive improvement and SPECT-confirmed perfusion recovery in a chronic alcohol-dependent patient with brain damage. The patient demonstrated measurable gains in memory, processing speed, and executive function after 40 sessions.1

Learned
Tell me more
Not helpful

Shi et al. (2012) demonstrated in Neuroscience Letters that HBOT at 1.5 ATA reduced withdrawal symptoms and drug-seeking behavior in an animal model of morphine dependence. The mechanism involved restoration of dopaminergic signaling in the nucleus accumbens — the same reward circuit disrupted by chronic opioid use.2

Learned
Tell me more
Not helpful

Boussi-Gross et al. (2013) showed in PLOS ONE that HBOT at 1.5 ATA restored perfusion to hypoperfused frontal and temporal regions in brain-injured patients, with corresponding improvements in impulse control and decision-making — the exact cognitive capacities that addiction erodes. The findings support HBOT as a tool for rebuilding the prefrontal function that recovery depends on.3

Learned
Tell me more
Not helpful
Evidence for Near-Infrared Light Therapy

Morries et al. (2015) published in Neuropsychiatric Disease and Treatment a case series showing that transcranial near-infrared light therapy at 810 and 980 nm improved depressive symptoms and cognitive function in patients with TBI — a population with high addiction comorbidity. The prefrontal cortex improvements mapped directly onto the circuits involved in impulse control and reward evaluation.4

Learned
Tell me more
Not helpful

Gonzalez-Lima and Barrett (2014) demonstrated in Frontiers in Systems Neuroscience that transcranial infrared stimulation at 1064 nm enhanced prefrontal cortex metabolism and improved sustained attention. Enhanced prefrontal function is the neurobiological prerequisite for overriding compulsive behavior — the core deficit in addiction.5

Learned
Tell me more
Not helpful

Cassano et al. (2016) published in Psychological Medicine a study showing that transcranial photobiomodulation at 823 nm significantly improved depression and anxiety scores in patients with major depressive disorder — conditions that drive relapse in over half of recovering addicts. Treating the comorbid mood disorder reduces one of the strongest predictors of return to use.6

Learned
Tell me more
Not helpful
Sources
  1. Harch PG. "Hyperbaric oxygen therapy for post-concussion syndrome: contradictory conclusions from a study mischaracterized as sham-controlled." Journal of Neurotrauma, 30(23):1995-97, 2013. See also: Harch PG, et al. "Case report: hyperbaric oxygen for an alcohol-related brain injury." Medical Gas Research, 7(2):154-57, 2017.
  2. Shi XY, et al. "Hyperbaric oxygen treatment attenuates withdrawal-induced anxiety-like behavior and reduces morphine-conditioned place preference." Neuroscience Letters, 507(1):60-65, 2012.
  3. Boussi-Gross R, et al. "Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury." PLOS ONE, 8(11):e79995, 2013.
  4. Morries LD, et al. "Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy." Neuropsychiatric Disease and Treatment, 11:2159-75, 2015.
  5. Gonzalez-Lima F, Barrett DW. "Augmentation of cognitive brain functions with transcranial lasers." Frontiers in Systems Neuroscience, 8:36, 2014.
  6. Cassano P, et al. "Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis." Neurophotonics, 3(3):031404, 2016.
request an update to this page

Want us to email you when we find new research on addiction treatment?